OGN vs USAC · P/E 3.4, rev $6.40B vs P/E 26, rev $950.4M
Organon & Co (OGN) versus USA Compression Partners LP (USAC) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
USA Compression Partners LP (USAC) is a oil & gas equipment & services company listed on NYSE.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported USAC revenue for 2024-12-31 was $950.4M. Net income was $99.6M. Revenue was up 12.3% from 2023-12-31 to 2024-12-31. USAC currently screens at market cap $3.70B and trailing P/E 26.1.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. USAC currently screens at market cap $3.70B and trailing P/E 26.1.
Not investment advice. Open the OGN and USAC stock pages for the full models.
Not investment advice.